Tiefeng Jin

1.8k total citations
65 papers, 1.3k citations indexed

About

Tiefeng Jin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Tiefeng Jin has authored 65 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 21 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Tiefeng Jin's work include RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (6 papers). Tiefeng Jin is often cited by papers focused on RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (6 papers). Tiefeng Jin collaborates with scholars based in China, South Korea and United States. Tiefeng Jin's co-authors include Zhenhua Lin, Hoe Suk Kim, Woo Kyung Moon, Lijuan Lin, Meihua Zhang, Liyan Chen, Yingshi Piao, Junjie Piao, Jienan Kong and Guanghai Yan and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and Gene.

In The Last Decade

Tiefeng Jin

65 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tiefeng Jin China	24	900	318	275	156	135	65	1.3k
Zhinong Jiang China	21	892 1.0×	425 1.3×	337 1.2×	231 1.5×	147 1.1×	71	1.6k
Georgios Kallifatidis United States	18	940 1.0×	364 1.1×	646 2.3×	214 1.4×	124 0.9×	26	1.7k
Dhiraj Kumar United States	15	735 0.8×	409 1.3×	423 1.5×	200 1.3×	98 0.7×	28	1.3k
Sung Jin Huh United States	11	457 0.5×	189 0.6×	486 1.8×	283 1.8×	83 0.6×	15	1.1k
Bedrich L. Eckhardt United States	19	741 0.8×	317 1.0×	626 2.3×	219 1.4×	156 1.2×	26	1.5k
Chang Hun Rhee South Korea	22	968 1.1×	405 1.3×	287 1.0×	122 0.8×	196 1.5×	34	1.8k
Nermin Kahraman United States	16	686 0.8×	373 1.2×	151 0.5×	90 0.6×	71 0.5×	32	913
Sven A. Lang Germany	24	928 1.0×	298 0.9×	449 1.6×	218 1.4×	174 1.3×	44	1.5k
Alexei V. Salnikov Germany	17	870 1.0×	433 1.4×	802 2.9×	183 1.2×	153 1.1×	23	1.6k
Haolong Li China	15	689 0.8×	322 1.0×	184 0.7×	107 0.7×	367 2.7×	35	1.2k

Countries citing papers authored by Tiefeng Jin

Since Specialization

Citations

This map shows the geographic impact of Tiefeng Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiefeng Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiefeng Jin more than expected).

Fields of papers citing papers by Tiefeng Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiefeng Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiefeng Jin. The network helps show where Tiefeng Jin may publish in the future.

Co-authorship network of co-authors of Tiefeng Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Tiefeng Jin. A scholar is included among the top collaborators of Tiefeng Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiefeng Jin. Tiefeng Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fu, Qiang, et al.. (2025). Ginsenoside RG3 Synergizes With STING Agonist to Reverse Cisplatin Resistance in Gastric Cancer. Food Science & Nutrition. 13(1). e4744–e4744. 1 indexed citations

Fu, Qiang, et al.. (2024). Bibliometric and visualized analysis of resveratrol in anticancer investigations. Food Science & Nutrition. 12(4). 2223–2239. 6 indexed citations

Fu, Qiang, et al.. (2024). Ginseng extract (Ginsenoside RG3) combined with STING agonist reverses TAM/M2 polarization to inhibit TNBC evolution. Industrial Crops and Products. 222. 119589–119589. 3 indexed citations

Zhang, Rui, et al.. (2024). LncRNA HAGLROS promotes breast cancer evolution through miR-135b-3p/COL10A1 axis and exosome-mediated macrophage M2 polarization. Cell Death and Disease. 15(8). 633–633. 25 indexed citations

Chang, Ying, et al.. (2024). Ginsenoside Rg3 combined with near‐infrared photothermal reversal of multidrug resistance in breast cancer MCF‐7/ADR cells. Food Science & Nutrition. 12(8). 5750–5761. 2 indexed citations

Fu, Qiang, et al.. (2022). Bibliometric and Visualized Analysis of the Current Status on STING Signaling Pathway and Cancer. Journal of Oncology. 2022. 1–12. 3 indexed citations

Zhang, Meihua, et al.. (2022). PD‐L1/p‐STAT3 promotes the progression of NSCLC cells by regulating TAM polarization. Journal of Cellular and Molecular Medicine. 26(23). 5872–5886. 8 indexed citations

Pan, Zongfu, Xiao Hu, Tiefeng Jin, et al.. (2022). CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment. Molecular Cancer. 21(1). 190–190. 68 indexed citations

Pan, Zongfu, Xiao Hu, Lu Li, et al.. (2022). IL2RA+VSIG4+ tumor-associated macrophage is a key subpopulation of the immunosuppressive microenvironment in anaplastic thyroid cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(1). 166591–166591. 25 indexed citations

10.

Zhang, Rui, et al.. (2021). Prognostic value of Mortalin correlates with roles in epithelial–mesenchymal transition and angiogenesis in lung adenocarcinoma. Carcinogenesis. 43(1). 40–51. 7 indexed citations

11.

Wang, Yixuan, et al.. (2020). Ezrin as a prognostic indicator regulates colon adenocarinoma progression through glycolysis. Journal of Gastroenterology and Hepatology. 36(3). 710–720. 7 indexed citations

12.

Zhang, Rui, et al.. (2020). Mortalin promotes breast cancer malignancy. Experimental and Molecular Pathology. 118. 104593–104593. 22 indexed citations

13.

Li, Nan, Jienan Kong, Zhenhua Lin, et al.. (2019). Ezrin promotes breast cancer progression by modulating AKT signals. British Journal of Cancer. 120(7). 703–713. 42 indexed citations

14.

Piao, Junjie, et al.. (2017). Paip1 affects breast cancer cell growth and represents a novel prognostic biomarker. Human Pathology. 73. 33–40. 21 indexed citations

15.

Wang, Yixuan, Jie Sun, Nan Li, et al.. (2017). HBXIP overexpression is correlated with the clinical features and survival outcome of ovarian cancer. Journal of Ovarian Research. 10(1). 26–26. 13 indexed citations

16.

Zhang, Meihua, Hoe Suk Kim, Tiefeng Jin, Ann Yi, & Woo Kyung Moon. (2016). Ultrasound-guided photoacoustic imaging for the selective detection of EGFR-expressing breast cancer and lymph node metastases. Biomedical Optics Express. 7(5). 1920–1920. 24 indexed citations

17.

Cui, Xuelian, et al.. (2014). NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer. Oncology Reports. 32(6). 2589–2595. 33 indexed citations

18.

Jin, Tiefeng, et al.. (2014). Study on the ERCC1 gene polymorphism response to chemotherapy and prognosis of gastric cancer. Genetics and Molecular Research. 13(4). 8722–8728. 12 indexed citations

19.

Lin, Lijuan, Junjie Piao, Yibing Ma, et al.. (2014). Mechanisms Underlying Cancer Growth and Apoptosis by DEK Overexpression in Colorectal Cancer. PLoS ONE. 9(10). e111260–e111260. 24 indexed citations

20.

Jin, Tiefeng, et al.. (2012). Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma. Diagnostic Pathology. 7(1). 135–135. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact